• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

慢性淋巴细胞白血病中对苯丁酸氮芥耐药的机制

Mechanisms of resistance to chlorambucil in chronic lymphocytic leukemia.

作者信息

Begleiter A, Goldenberg G J, Anhalt C D, Lee K, Mowat M R, Israels L G, Johnston J B

机构信息

Department of Internal Medicine, University of Manitoba, Canada.

出版信息

Leuk Res. 1991;15(11):1019-27. doi: 10.1016/0145-2126(91)90107-5.

DOI:10.1016/0145-2126(91)90107-5
PMID:1961006
Abstract

The postulated biochemical mechanisms responsible for clinical resistance to chlorambucil (CLB) in chronic lymphocytic leukemia (CLL) have been examined. The total sulfhydryl, non-protein-bound sulfhydryl, protein-bound sulfhydryl (PSH) and glutathione (GSH) levels, in addition to glutathione S-transferase (GST) activities, were measured in the leukemic cells of 18 CLL patients. In addition, the formation and repair of DNA cross-links were measured following incubation of the cells with 100 microM chlorambucil in vitro. These parameters were then correlated with the subsequent clinical responses of the patients, as measured by the percent fall in lymphocyte count 3 weeks following 0.9 mg/kg chlorambucil. No correlations were observed between any of the individual parameters and clinical response, although a slight positive correlation was observed between the PSH:GSH ratio and clinical response. These findings suggest that multiple mechanisms may contribute to CLB-resistance in CLL.

摘要

对慢性淋巴细胞白血病(CLL)中与苯丁酸氮芥(CLB)临床耐药相关的假定生化机制进行了研究。测定了18例CLL患者白血病细胞中的总巯基、非蛋白结合巯基、蛋白结合巯基(PSH)和谷胱甘肽(GSH)水平,以及谷胱甘肽S-转移酶(GST)活性。此外,在体外将细胞与100μM苯丁酸氮芥孵育后,测定DNA交联的形成和修复情况。然后将这些参数与患者随后的临床反应相关联,临床反应通过给予0.9mg/kg苯丁酸氮芥3周后淋巴细胞计数下降的百分比来衡量。尽管观察到PSH:GSH比值与临床反应之间存在轻微正相关,但未观察到任何单个参数与临床反应之间的相关性。这些发现表明,多种机制可能导致CLL对苯丁酸氮芥产生耐药性。

相似文献

1
Mechanisms of resistance to chlorambucil in chronic lymphocytic leukemia.慢性淋巴细胞白血病中对苯丁酸氮芥耐药的机制
Leuk Res. 1991;15(11):1019-27. doi: 10.1016/0145-2126(91)90107-5.
2
Glutathione S-transferase activity, sulfhydryl group and glutathione levels, and DNA cross-linking activity with chlorambucil in chronic lymphocytic leukemia.
J Natl Cancer Inst. 1990 May 2;82(9):776-9. doi: 10.1093/jnci/82.9.776.
3
Chlorambucil in chronic lymphocytic leukemia: mechanism of action.苯丁酸氮芥治疗慢性淋巴细胞白血病:作用机制
Leuk Lymphoma. 1996 Oct;23(3-4):187-201. doi: 10.3109/10428199609054821.
4
Reversing of chlorambucil resistance by ethacrynic acid in a B-CLL patient.依他尼酸对一位慢性淋巴细胞白血病患者苯丁酸氮芥耐药性的逆转作用
Br J Haematol. 1993 Oct;85(2):409-10. doi: 10.1111/j.1365-2141.1993.tb03187.x.
5
Drug resistance mechanisms in chronic lymphocytic leukemia.慢性淋巴细胞白血病中的耐药机制
Leukemia. 1996 Dec;10(12):1944-9.
6
Chemosensitivity of lymphocytes from patients with B-cell chronic lymphocytic leukemia to chlorambucil, fludarabine, and camptothecin analogs.B 细胞慢性淋巴细胞白血病患者淋巴细胞对苯丁酸氮芥、氟达拉滨和喜树碱类似物的化学敏感性。
Blood. 1994 Nov 15;84(10):3440-6.
7
Potentiation of chlorambucil cytotoxicity in B-cell chronic lymphocytic leukemia by inhibition of DNA-dependent protein kinase activity using wortmannin.渥曼青霉素通过抑制DNA依赖性蛋白激酶活性增强苯丁酸氮芥对B细胞慢性淋巴细胞白血病的细胞毒性作用
Cancer Res. 1998 May 1;58(9):1789-92.
8
Studies on drug resistance in chronic lymphocytic leukemia.
Adv Enzyme Regul. 1989;29:267-76. doi: 10.1016/0065-2571(89)90106-4.
9
Characterization of glutathione S-transferase expression in lymphocytes from chronic lymphocytic leukemia patients.慢性淋巴细胞白血病患者淋巴细胞中谷胱甘肽S-转移酶表达的特征分析
Cancer Res. 1990 Jun 15;50(12):3562-8.
10
Nitrogen mustard drug resistant B-cell chronic lymphocytic leukemia as an in vivo model for crosslinking agent resistance.氮芥耐药B细胞慢性淋巴细胞白血病作为交联剂耐药的体内模型。
Mutat Res. 1995 May;336(3):269-78. doi: 10.1016/0921-8777(94)00063-c.

引用本文的文献

1
Drug resistance and DNA repair in leukaemia.白血病的耐药性和 DNA 修复。
Cytotechnology. 1998 Sep;27(1-3):175-85. doi: 10.1023/A:1008064804678.